ENTRY       D11709                      Drug
NAME        Ascrinvacumab (USAN/INN)
FORMULA     C6396H9850N1694O2012S44
EXACT_MASS  143988.8233
MOL_WEIGHT  144077.6488
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSQTLSL TCTVSGGSIS SGEYYWNWIR QHPGKGLEWI GYIYYSGSTY
            YNPSLKSRVT ISVDTSKNQF SLKLSSVTAA DTAVYYCARE SVAGFDYWGQ GTLVTVSSAS
            TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSNFGTQTYT CNVDHKPSNT KVDKTVERKC CVECPPCPAP PVAGPSVFLF
            PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTFRVV
            SVLTVVHQDW LNGKEYKCKV SNKGLPAPIE KTISKTKGQP REPQVYTLPP SREEMTKNQV
            SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPMLDSDGS FFLYSKLTVD KSRWQQGNVF
            SCSVMHEALH NHYTQKSLSL SPGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GTSSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H97, H132-L215, H145-H201, H220-H'220, H221-H'221, H224-H'224, H227-H'227, H258-H318, H364-H422, H'22-H'97, H'132-L'215, H'145-H'201, H'258-H'318, H'364-H'422, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-activin receptor-like kinase antibody
  TYPE      Monoclonal antibody
TARGET      ACVRL1 [HSA:94] [KO:K13594]
  PATHWAY   hsa04060(94)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor serine/threonine kinases (RSTK)
               TGFBR1 family
                ACVRL1
                 D11709  Ascrinvacumab (USAN/INN)
DBLINKS     CAS: 1463459-96-2
            PubChem: 405226575
///
